Skip to content

Released May 9, 2019, after the close

10-Q filed May 9, 2019, 39 days after period end · 0001144204-19-024904

Q1 2019 · 10-Q
Revenue$3.89M+9.0% vs Q1 2018+4.0% vs Q4 2018
Net Income-$27.05MN/M vs Q1 2018N/M vs Q4 2018
EPS Diluted-$1.05N/M vs Q1 2018N/M vs Q4 2018
Operating Income-$28,336,000N/M
Operating Cash Flow-$23,939,000N/M
Free Cash Flowderived-$25,427,000N/M
Margins · derived
Operating margin-729.4%−261.7 pt vs Q1 2018
Net margin-696.3%−240.5 pt vs Q1 2018

What the release said

The release

Same quarter

MetricQ1 2019Q1 2018Q1 2017Q1 2016
Revenue$3.89M$3.57M$684.00K—
Net Income-$27.05M-$16.25M-$13.93M-$10.99M
EPS Diluted-$1.05-$0.80-$810.00-$0.64

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR